Abstract
Background. A 36-year-old African American man with end-stage renal disease on chronic maintenance hemodialysis was transferred first from a hospital to a long-term acute care facility for advanced care then to the intensive care unit of our university hospital with unexplained abdominal pain, nausea, hypotension, altered mental status and anion gap metabolic acidosis. Subsequent review of the patient's medication list revealed that the he had been on linezolid for 6 weeks for the treatment of vancomycin-resistant Enterococcus fecalis bacteremia.
Investigations. Medical history, physical examination, laboratory tests, CT imaging of the thorax, abdomen and pelvis and PCR-based tests to determine the presence of polymorphisms in the 16S ribosomal RNA gene.
Diagnosis. Lactic acidosis associated with prolonged exposure to linezolid.
Management. Discontinuation of linezolid.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Palenzuela, L. et al. Does linezolid cause lactic acidosis by inhibiting mitochondrial protein synthesis? Clin. Infect. Dis. 40, e113–e116 (2005).
Misbin, R. I. Phenformin-associated lactic acidosis: pathogenesis and treatment. Ann. Intern. Med. 87, 591–595 (1977).
Leach, K. L. et al. The site of action of oxazolidinone antibiotics in living bacteria and in human mitochondria. Mol. Cell. 26, 393–402 (2007).
Wilson, D. N. et al. The oxazolidinone antibiotics perturb the ribosomal peptidyl-transferase center and effect tRNA positioning. Proc. Natl Acad. Sci. USA 105, 13339–13344 (2008).
Thompson, J., O'Connor, M., Mills, J. A. & Dahlberg, A. E. The protein synthesis inhibitors, oxazolidinones and chloramphenicol, cause extensive translational inaccuracy in vivo. J. Mol. Biol. 322, 273–279 (2002).
Sharma, M. R. et al. Structure of the mammalian mitochondrial ribosome reveals an expanded functional role for its component proteins. Cell 115, 97–108 (2003).
McKee, E. E., Ferguson, M., Bentley, A. T. & Marks, T. A. Inhibition of mammalian mitochondrial protein synthesis by oxazolidinones. Antimicrob. Agents Chemother. 50, 2042–2049 (2006).
Nagiec, E. E. et al. Oxazolidinones inhibit cellular proliferation via inhibition of mitochondrial protein synthesis. Antimicrob. Agents Chemother. 49, 3896–3902 (2005).
Soriano, A., Miró, O. & Mensa, J. Mitochondrial toxicity associated with linezolid. N. Engl. J. Med. 353, 2305–2306 (2005).
Carson, J., Cerda, J., Chae, J. H., Hirano, M. & Maggiore, P. Severe lactic acidosis associated with linezolid use in a patient with the mitochondrial DNA A2706G polymorphism. Pharmacotherapy 27, 2771–2774 (2007).
Naranjo, C. A. et al. A method for estimating the probability of adverse drug reactions. Clin. Pharmacol. Ther. 30, 239–245 (1981).
Narita, M., Tsuji, B. T. & Yu, V. L. Linezolid-associated peripheral and optic neuropathy, lactic acidosis, and serotonin syndrome. Pharmacotherapy 27, 1189–1197 (2007).
Apodaca, A. A. & Rakita, R. M. Linezolid-induced lactic acidosis. N. Engl. J. Med. 348, 86–87 (2003).
Garrabou, G. et al. Reversible inhibition of mitochondrial protein synthesis during linezolid-related hyperlactatemia. Antimicrob. Agents Chemother. 51, 962–967 (2007).
Thorell, E. A., Sharma, M., Jackson, M. A., Selvarangan, R. & Woods, G. M. Disseminated nontuberculous mycobacterial infections in sickle cell anemia patients. J. Pediatr. Hematol. Oncol. 28, 678–681 (2006).
Boutoille, D., Grossi, O., Depatureaux, A. & Tattevin, P. Fatal lactic acidosis after prolonged linezolid exposure for treatment of multidrug-resistant tuberculosis. Eur. J. Intern. Med. 20, e134–e135 (2009).
Fernández de Orueta, L., Díaz, V., Ramírez, M. & Alvarez, R. Linezolid-induced lactic acidosis [Spanish]. Enferm. Infecc. Microbiol. Clin. 27, 550–551 (2009).
De Vriese, A. S. et al. Linezolid-induced inhibition of mitochondrial protein synthesis. Clin. Infect. Dis. 42, 1111–1117 (2006).
Bernard, L., Stern, R., Lew, D. & Hoffmeyer, P. Serotonin syndrome after concomitant treatment with linezolid and citalopram. Clin. Infect. Dis. 36, 1197 (2003).
Bishop, E., Melvani, S., Howden, B. P., Charles, P. G. & Grayson, M. L. Good clinical outcomes but high rates of adverse reactions during linezolid therapy for serious infections: a proposed protocol for monitoring therapy in complex patients. Antimicrob. Agents Chemother. 50, 1599–1602 (2006).
Scotton, P. et al. Early linezolid-associated lactic acidosis in a patient treated for tuberculous spondylodiscitis. Infection 36, 387–388 (2008).
Wiener, M., Guo, Y., Patel, G. & Fries, B. C. Lactic acidosis after treatment with linezolid. Infection 35, 278–281 (2007).
Lee, Y. R. et al. Early development of lactic acidosis with short term linezolid treatment in a renal recipient. J. Chemother. 20, 766–767 (2008).
Kopterides, P., Papadomichelakis, E. & Armaganidis, A. Linezolid use associated with lactic acidosis. Scand. J. Infect. Dis. 37, 153–154 (2005).
Pea, F. et al. Hyperlactacidemia potentially due to linezolid overexposure in a liver transplant recipient. Clin. Infect. Dis. 42, 434–435 (2006).
Vu, N.-S. D. & Walia, R. Linezolid-induced lactic acidosis [abstract]. Chest 130, 337–338 (2006).
Beekmann, S. E., Gilbert, D. N. & Polgreen, P. M. Toxicity of extended courses of linezolid: results of an Infectious Diseases Society of America Emerging Infections Network survey. Diagn. Microbiol. Infect. Dis. 62, 407–410 (2008).
Herrnstadt, C. et al. Reduced-median-network analysis of complete mitochondrial DNA coding-region sequences for the major African, Asian, and European haplogroups. Am. J. Hum. Genet. 70, 1152–1171 (2002).
Suzuki, T. et al. Structural compensation for the deficit of rRNA with proteins in the mammalian mitochondrial ribosome. Systematic analysis of protein components of the large ribosomal subunit from mammalian mitochondria. J. Biol. Chem. 276, 21724–21736 (2001).
Haas, R. H. et al. The in-depth evaluation of suspected mitochondrial disease. Mol. Genet. Metab. 94, 16–37 (2008).
Wynalda, M. A., Hauer, M. J. & Wienkers, L. C. Oxidation of the novel oxazolidinone antibiotic linezolid in human liver microsomes. Drug Metab. Dispos. 28, 1014–1017 (2000).
Stalker, D. J. & Jungbluth, G. L. Clinical pharmacokinetics of linezolid, a novel oxazolidinone antibacterial. Clin. Pharmacokinet. 42, 1129–1140 (2003).
Brier, M. E. et al. Pharmacokinetics of linezolid in subjects with renal dysfunction. Antimicrob. Agents Chemother. 47, 2775–2780 (2003).
Chodock, R. et al. Survival of a human immunodeficiency patient with nucleoside-induced lactic acidosis--role of haemodialysis treatment. Nephrol. Dial. Transplant. 14, 2484–2486 (1999).
Roy, P. M., Gouello, J. P., Pennison-Besnier, I. & Chennebault, J. M. Severe lactic acidosis induced by nucleoside analogues in an HIV-infected man. Ann. Emerg. Med. 34, 282–284 (1999).
Fiaccadori, E. et al. Removal of linezolid by conventional intermittent hemodialysis, sustained low-efficiency dialysis, or continuous venovenous hemofiltration in patients with acute renal failure. Crit. Care Med. 32, 2437–2442 (2004).
Acknowledgements
The research work of Dr. J. C. Q. Velez is supported by a NIH NIDDK K08 Career Development Award. The research work of Dr. M. G. Janech is supported by a Veterans Affairs CDA-2 Career Development Award and the Nephcure Foundation.
Charles P. Vega, University of California, Irvine, CA, is the author of and is solely responsible for the content of the learning objectives, questions and answers of the MedscapeCME continuing medical education activity associated with this article.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors, the Journal Editor S. Allison and the CME questions author C. P. Vega declare no competing interests.
Rights and permissions
About this article
Cite this article
Velez, J., Janech, M. A case of lactic acidosis induced by linezolid. Nat Rev Nephrol 6, 236–242 (2010). https://doi.org/10.1038/nrneph.2010.20
Issue Date:
DOI: https://doi.org/10.1038/nrneph.2010.20
This article is cited by
-
Comparative analysis of lactic acidosis induced by linezolid and vancomycin therapy using cohort and case–control studies of incidence and associated risk factors
European Journal of Clinical Pharmacology (2018)